Photographs for “Die zweite Stimme” magazine campaign

May, 23 2018

Dear long-term-survivors,

twice a year the “Deutsche Stiftung für Eierstockkrebs” publishes their magazine “Die zweite Stimme”. For the upcoming (Q4 2018/Q1 2019) issue we are looking for photos of long-term-survivors to bolster up affected women.

Beside this campaign, where we would like you to send in your personal photos, we are going to additionally hire a professional photographer for fall/autumn 2018 to shoot portraits of our patients.

Our main goal is to set up a circulating exhibition with the collection of these artistically staged photos.

We would like to point out the strong women who are constantly fighting against ovarian cancer.

Please feel free to get to us with our contact form.

 

Prof. Sehouli Discusses Unmet Needs in Ovarian Cancer

January 08, 2018

Jalid Sehouli, MD, professor, director of the Clinic Campus Virchow and Campus Benjamin Franklin Charité Center Gynecology, Charité – Universitatsmedizin Berlin, discusses the unmet needs for patients with ovarian cancer.

There are many unmet needs, says Sehouli, because patients with ovarian cancer live longer but the cure rate still remains low. Increasing the standard of care could improve patient outcomes since not all patients receive the adequate treatment, explains Sehouli.

Further biomarker development could improve the identification of patients who need a maintenance approach.

Prof. Jalid Sehouli, Berlin, to new study results about ovarian cancer from ESGO-Kongress 2017

11. November 2017

Last year’s congress of the European Society of Gynaecological Oncology has brought new results for curative treatment of advanced ovarian cancer – the most common cause of ascites. Patients can soon benefit by a new targeted therapy. Furthermore there has also been a transition to more lymph node obtaining surgeries.

Besides that Prof. Sehouli presents the interesting results of a medical survey about therapy goals and preferences of patients with ovarian cancer (German):

 

 

Source: https://www.maligner-aszites.de/patienten/maligner-aszites/eierstockkrebs-neue-op-standards-und-die-aussicht-auf-eine-neue-zielgerichtete-therapie.html